Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer

被引：0
|
作者：
Lian Jiang
Dao-yuan Wang
Zhi-hua Zhu
Liang-fa Tang
Xin-heng Hou
Hong-da Zhao
Zheng Xie
Dan-feng Wang
机构：
[1] Nantong University,Department of Respiratory Medicine, Jiangyin People’s Hospital
[2] Sun Yat-sen University,Department of Thoracic Oncology, State Key Laboratory of Oncology in South China, Cancer Center, Lung Cancer Research Center
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
Advanced non-small cell lung cancer; Docetaxel; Carboplatin; Weekly;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：449 / 453
页数：4
相关论文
共 50 条
  • [41] Phase II study of weekly carboplatin and irinotecan as first-line chemotherapy for patients with advanced non-small cell lung cancer
    Kim, Hyeong Su
    Kim, Jung Han
    Kim, Byounghoon
    Choi, Hyun Chang
    Kwon, Jung Hye
    Choi, Dae Ro
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1591 - 1597
  • [42] Cisplatin and weekly docetaxel as first-line therapy in patients with advanced non-small cell lung cancer a phase II study
    Tartarone, A
    Romano, G
    Iodice, G
    Capobianco, A
    Coccaro, M
    Bochicchio, A
    Di Leo, P
    Ardito, R
    Di Renzo, N
    [J]. TUMORI, 2005, 91 (02) : 131 - 134
  • [43] Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancer
    Miller, Antonius A.
    Case, Doug
    Atkins, James N.
    Giguere, Jeffrey K.
    Bearden, James D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (08) : 832 - 836
  • [44] A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer
    Fidias, P
    Supko, JG
    Martins, R
    Boral, A
    Carey, R
    Grossbard, M
    Shapiro, G
    Ostler, P
    Lucca, J
    Johnson, BE
    Skarin, A
    Lynch, TJ
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (12) : 3942 - 3949
  • [45] A PHASE II TRIAL OF WEEKLY DOCETAXEL COMBINED WITH CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG CANCER
    Nong, X.
    Zhang, X.
    Xiong, J.
    Fang, W.
    Zhang, L.
    Zhong, L.
    Chen, J.
    Yu, F.
    Qian, J.
    Deng, J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 157 - 157
  • [46] Phase I trial of weekly docetaxel combined with cisplatin in patients with non-small cell lung cancer
    Koizumi, T
    Tsunoda, T
    Fujimoto, K
    Nomura, H
    Hirai, K
    Koyama, S
    Okada, K
    Kubo, K
    [J]. LUNG CANCER, 2001, 34 (01) : 125 - 131
  • [47] A Phase II Study of Concurrent Chemoradiation with Weekly Docetaxel, Carboplatin, and Radiation Therapy Followed by Consolidation Chemotherapy with Docetaxel and Carboplatin for Locally Advanced Inoperable Non-small Cell Lung Cancer (NSCLC)
    Jain, Anshu K.
    Hughes, Randall S.
    Sandler, Alan B.
    Dowlati, Afshin
    Schwartzberg, Lee S.
    Dobbs, Tracy
    Schlabach, Larry
    Wu, Jean
    Muldowney, Nancy J.
    Choy, Hak
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (06) : 722 - 727
  • [48] A phase II trial of concurrent radiochemotherapy with carboplatin (CBDCA) and weekly docetaxel (TXT) in locally advanced non-small cell lung cancer (NSCLC).
    Suzuki, R
    Taniguchi, H
    Kondoh, Y
    Shindoh, J
    Matsumoto, S
    Hiramatsu, T
    Gonda, H
    Baba, K
    Hasegawa, Y
    Shimokata, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 659S - 659S
  • [49] Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer
    Park, Se Hoon
    Hong, Junshik
    Kim, Young Saing
    Kim, Yujin
    Kyung, Sun Young
    An, Chang Hyeok
    Lee, Sang Pyo
    Park, Jeong Woong
    Jeong, Sung Hwan
    Park, Jinny
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae Hoon
    [J]. LUNG CANCER, 2008, 62 (01) : 72 - 77
  • [50] Randomized phase II study of gemcitabine and carboplatin +/- sequential docetaxel in non-small cell lung cancer
    Hillerdal, Gunnar
    Sederholm, Christer
    Andersson, Kerstin
    [J]. LUNG CANCER, 2011, 71 (02) : 178 - 181
12345